{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:59:39Z","timestamp":1784836779289,"version":"3.55.0"},"reference-count":19,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2026,3,27]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>A recent international survey of clinician practices in the management of Clostridioides difficile infections (CDIs) identified numerous areas of practice heterogeneity. The degree of practice variability within Canada is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data from Canadian participants of an international survey of clinician CDI practices were extracted. Practice alignment with the Association of Medical Microbiology and Infectious Disease (AMMI) Canada CDI treatment guidelines was assessed. CDI practices were compared across provinces using the Fisher exact test with a simulated P value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 112 responses were obtained from eight provinces. Vancomycin (85.3% for first episode), vancomycin pulse and taper (P-T) (61.8% and 32.4% for first and second recurrences, respectively), and fecal microbiota transplant (32.4% for third recurrence) were preferred treatment strategies. Practice alignment with the AMMI Canada CDI guidelines for the treatment of recurrences was low (range 23.5%\u201332.4%, depending on the recurrence number). With respect to secondary CDI prophylaxis during antibiotic reexposure, there were interprovincial differences in the perceived indication ( P = .03), whether to prescribe at all ( P &lt; .001), and duration of prophylaxis ( P = .004). There was significant clinician support (&gt;50%) for randomized clinical trials testing treatment strategies for recurrent episodes and for secondary prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Despite the availability of national guidelines, we found significant heterogeneity in practice across Canada, often not aligned with guideline recommendations. These findings underscore the need for a platform trial comparing treatment strategies and a trial to establish the efficacy of secondary prophylaxis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3138\/jammi-2025-0014","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:39:18Z","timestamp":1774874358000},"page":"37-50","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis, treatment, and prophylaxis of\n                    <i>Clostridioides difficile<\/i>\n                    infections: A cross-sectional survey of Canadian clinicians"],"prefix":"10.3138","volume":"11","author":[{"given":"Connor","family":"Prosty","sequence":"first","affiliation":[{"name":"Faculty of Medicine, McGill University, Montr\u00e9al, Quebec, Canada"},{"name":"Division of Experimental Medicine, Department of Medicine, McGill University, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennet","family":"Desormeau","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, McGill University, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, Department of Medicine, McGill University, Montr\u00e9al, Quebec, Canada"},{"name":"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Quebec, Montr\u00e9al, Canada"},{"name":"Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G","family":"McDonald","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, Department of Medicine, McGill University, Montr\u00e9al, Quebec, Canada"},{"name":"Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montr\u00e9al, Quebec, Canada"},{"name":"Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","reference":[{"issue":"1","key":"r1","doi-asserted-by":"crossref","first-page":"010407","DOI":"10.7189\/jogh.09.010407","volume":"9","author":"Balsells E","year":"2019","journal-title":"J Glob Health"},{"issue":"3","key":"r2","doi-asserted-by":"crossref","first-page":"ofv076","DOI":"10.1093\/ofid\/ofv076","volume":"2","author":"Levy AR","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"r3","first-page":"191","volume":"45","author":"Xia Y","year":"2019","journal-title":"Can Commun Dis Rep Releve Mal Transm Au Can"},{"issue":"36","key":"r4","doi-asserted-by":"crossref","first-page":"E981","DOI":"10.1503\/cmaj.190361","volume":"191","author":"Mitchell R","year":"2019","journal-title":"CMAJ"},{"key":"r5","doi-asserted-by":"publisher","DOI":"10.3138\/jammi.2018.02.13"},{"issue":"5","key":"r6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"Louie TJ","year":"2011","journal-title":"N Engl J Med"},{"issue":"15","key":"r7","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s40265-022-01797-x","volume":"82","author":"Khanna S","year":"2022","journal-title":"Drugs"},{"issue":"3","key":"r8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa2106516","volume":"386","author":"Feuerstadt P","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"r9","doi-asserted-by":"crossref","first-page":"dlac138","DOI":"10.1093\/jacamr\/dlac138","volume":"5","author":"Patel D","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"r10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","volume":"27","author":"van Prehn J","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"r11","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","volume":"73","author":"Johnson S","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6","key":"r12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","volume":"116","author":"Kelly CR","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"r13","doi-asserted-by":"crossref","first-page":"ofaf248","DOI":"10.1093\/ofid\/ofaf248","volume":"12","author":"Prosty C","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"r14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2307\/2983177","volume":"159","author":"Smith PWF","year":"1996","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"r15","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","volume-title":"Ggplot2: Elegant Graphics for Data Analysis","author":"Wickham H","year":"2009"},{"key":"r16","unstructured":"RAWGraphs. Accessed December 9, 2024. https:\/\/www.rawgraphs.io\/"},{"issue":"10","key":"r17","doi-asserted-by":"crossref","first-page":"ofae524","DOI":"10.1093\/ofid\/ofae524","volume":"11","author":"Dubberke ER","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"r18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/cid\/ciae467","volume":"80","author":"Drekonja DM","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"2","key":"r19","doi-asserted-by":"crossref","first-page":"105041","DOI":"10.1016\/j.cmicom.2024.105041","volume":"1","author":"Prosty C","year":"2024","journal-title":"CMI Commun"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2025-0014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:39:44Z","timestamp":1774874384000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2025-0014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3,27]]}},"alternative-id":["10.3138\/jammi-2025-0014"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2025-0014","relation":{},"ISSN":["2371-0888"],"issn-type":[{"value":"2371-0888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]}}}